Sublingual sermorelin for anti-aging: what the evidence actually shows

What did @_life_with_kaitlyn actually say?

The creator says sermorelin can be combined with semaglutide, describing sermorelin as "your rejuvenating peptide" that helps with "collagen elasticity." She walks through a switch from injectable sermorelin to a sublingual troche, taken five days a week, and plugs Ibine Health as a provider with a $75 monthly membership fee. There's a disclaimer about licensed medical supervision, which is worth noting.

To be fair, she's not claiming sermorelin cures anything. She's framing it as a complementary peptide to a GLP-1 regimen and describing a delivery format change. That framing is less reckless than a lot of peptide content on TikTok. But there are gaps in what she tells her 52,000-plus viewers, and the "collagen elasticity" claim deserves a hard look.

Does the science back this up?

Partially, and the details matter. Sermorelin is a growth hormone-releasing hormone (GHRH) analogue. It stimulates the pituitary gland to produce endogenous growth hormone, rather than introducing exogenous GH directly. That distinction matters clinically. The evidence base is real but narrow.

On the collagen claim specifically: growth hormone does influence collagen synthesis. A randomized controlled trial by Lange et al. (2002, Journal of Clinical Endocrinology and Metabolism) found GH administration increased collagen turnover markers. But sermorelin is not GH. It's a secretagogue. The downstream effects on collagen in healthy, non-GH-deficient adults are extrapolated, not directly studied in large trials. So "collagen elasticity" as a promised benefit of sermorelin in a general wellness population is a stretch the evidence doesn't fully support.

On the troche delivery: sublingual and buccal troches for peptides are increasingly used in compounding pharmacies, but absorption data for sermorelin via this route is limited. A 2018 review by Walker (Peptides) noted that peptide bioavailability through mucosal routes varies substantially by molecular weight and formulation. Sermorelin's relatively small size (29 amino acids) makes buccal absorption more plausible than for larger peptides, but "works just like the injection did" is not established by published equivalency data.

What did they get wrong (or right)?

Wrong: The claim that sublingual sermorelin works "just like the injection did" is not supported by published bioequivalence data. Injection delivers peptides directly into systemic circulation. Buccal/sublingual absorption is subject to enzymatic degradation in saliva and variable mucosal permeability. That doesn't mean troches don't work, but calling them equivalent to injections oversimplifies the pharmacokinetics.

Also wrong, or at least unsubstantiated: framing "collagen elasticity" as a well-established sermorelin benefit. This is a downstream inference from GH biology, not a direct finding from sermorelin trials in general wellness populations.

Right: The basic premise that sermorelin can be used alongside a GLP-1 agonist like semaglutide is not inherently contraindicated, and some clinicians do prescribe both. She correctly identifies that different providers can manage each therapy separately. She also correctly names the delivery format as a troche (after a couple of attempts at the word). The disclaimer about licensed medical supervision is appropriate, even if it's brief.

What should you actually know?

Sermorelin is FDA-approved for GH deficiency in children, but its use in adults for anti-aging or body composition is off-label. Off-label use isn't automatically dangerous, but it means the evidence base is thinner and the regulatory oversight is lighter.

Troches are compounded formulations. Under current FDA and FTC guidelines, compounded drugs cannot be marketed as equivalent to FDA-approved injectables. If you're told a troche "works just like the injection," ask your provider for the pharmacokinetic data behind that claim, because it likely doesn't exist for your specific formulation.

Combining sermorelin with semaglutide raises a practical question worth asking a real clinician: semaglutide suppresses appetite and can reduce lean mass. Some providers add a GH secretagogue to help preserve muscle. That rationale has logic behind it, but the combination hasn't been studied in a controlled trial. Anyone selling this stack as proven is ahead of the evidence.

Finally, a $75 monthly membership fee on top of medication costs is a real expense. It's not inherently predatory, but it's worth understanding what you're paying for before committing.